Olink Holding AB (publ) (OLK) Stock Price, News & Analysis

Company Overview

Olink Holding AB (publ) develops, produces, markets, and sells biotechnological products and services for the academic, government, biopharmaceutical, biotechnology, service provider, and other institutions that focuses on life science research. The company's products include Olink Explore that consist of Explore 372 and Explore 384 for cardiovascular and metabolic, oncology, neurology, and inflammation diseases; Olink Target product line; Olink Flex, a low-plex applications and use-cases; and Olink Focus product line that consists of custom developed solutions for customers that has identified various proteins of interest or a protein signature to focus on. Its products also comprise Olink Signature Q100, a qPCR readout platform; Olink Analysis services comprising study design and consultation, sample preparation and assay execution, and data processing and QC; and data analysis and bioinformatics services. In addition, the company offers Olink normalized protein expression (NPX) data processing software, a purpose-built software that enable users to import data, perform data analysis including visualizations, and statistical modelling; and Olink Insight, a cloud platform for Olink community to accelerate proteomics. It sells its products and services through its own direct sales force in Sweden, the United States, rest of the Americas, rest of Europe, the Middle East, Africa, Japan, and internationally. The company was formerly known as Knilo HoldCo AB and changed its name to Olink Holding AB (publ) in January 2021. Olink Holding AB (publ) was founded in 2004 and is headquartered in Uppsala, Sweden.

Key Stats

• Today's Range: $26.08 to $26.08
• 50-Day Range: $26.08 to $26.08
• 52-Week Range: $14.10 to $26.09
• Volume: 1,000 shs
• Average Volume: 633,228 shs
• Market Capitalization: $3.24 billion
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: $26.00
• Consensus Rating: Hold

OLK Stock Analysis - Frequently Asked Questions

How were Olink Holding AB (publ)'s earnings last quarter?

Olink Holding AB (publ) (NASDAQ:OLK) announced its quarterly earnings data on Monday, May, 13th. The company reported ($0.13) EPS for the quarter, missing the consensus estimate of ($0.12) by $0.01. The company had revenue of $28.75 million for the quarter, compared to analyst estimates of $31.29 million. Olink Holding AB (publ) had a negative trailing twelve-month return on equity of 7.07% and a negative net margin of 19.72%.

When did Olink Holding AB (publ) IPO?

Olink Holding AB (publ) (OLK) raised $301 million in an IPO on Thursday, March 25th 2021. The company issued 17,700,000 shares at a price of $16.00-$18.00 per share. Goldman Sachs, Morgan Stanley and SVB Leerink served as the underwriters for the IPO and BTIG was co-manager.

Who are Olink Holding AB (publ)'s major shareholders?

Top institutional shareholders of Olink Holding AB (publ) include XTX Topco Ltd (0.01%).

What other stocks do shareholders of Olink Holding AB (publ) own?

Based on aggregate information from My MarketBeat watchlists, some other companies that Olink Holding AB (publ) investors own include MSP Recovery (LIFW), MSP Recovery (LIFW), Adobe (ADBE), Devon Energy (DVN), Silicon Motion Technology (SIMO), Teradyne (TER) and WPP (WPP).

Company Calendar

• Last Earnings: 5/13/2024
• Today: 11/17/2024
• Fiscal Year End: 12/31/2024

Industry, Sector and Symbol

• Stock Exchange: NASDAQ
• Sector: Medical
• Industry: Analytical instruments
• Sub-Industry: Measuring And Control Equipment
• Current Symbol: NASDAQ:OLK
• CUSIP: N/A
• CIK: 1835539
• Web: www.olink.com
• Phone: 46 (0) 18 444 39 70
• Fax: N/A
• Employees: 420
• Year Founded: N/A

Price Target and Rating

• Average Stock Price Target: $26.00
• High Stock Price Target: $26.00
• Low Stock Price Target: $26.00
• Potential Upside/Downside: -0.3%
• Consensus Rating: Hold
• Rating Score (0-4): 2.00
• Research Coverage: 2 Analysts

Profitability

• EPS (Most Recent Fiscal Year): ($0.27)
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: $-31,600,000.00
• Net Margins: -19.72%
• Pretax Margin: -24.84%
• Return on Equity: -7.07%
• Return on Assets: -6.05%

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: 5.60
• Quick Ratio: 3.91

Sales & Book Value

• Annual Sales: $170.89 million
• Price / Sales: 18.98
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: $4.04 per share
• Price / Book: 6.46

Miscellaneous

• Outstanding Shares: 124,343,000
• Free Float: 117,877,000
• Market Cap: $3.24 billion
• Optionable: Optionable
• Beta: 0.52